- Amgen, headquartered in Thousand Oaks, California, is a leading biotechnology company focused on developing innovative therapies for serious diseases, achieving total revenues of $36.8 billion in 2025, a 10% increase from 2024.
- In 2025, Amgen reported strong financial performance with a 111% increase in GAAP earnings per share for Q4, driven by higher revenues and a broad portfolio of medicines, including 18 products that achieved record sales.
- The company serves approximately 17 million patients globally and has established key partnerships that enhance its market reach and product development capabilities.
- Amgen's ideal buyers are healthcare providers and institutions seeking advanced biopharmaceutical solutions to address serious medical conditions, making it essential for sales teams to engage with them as the company continues to expand its innovative product offerings.
Amgen's workforce is organized into 19 departments, with Operations leading at 2,411 employees, followed by Information Technology with 1,906 and the Executive department at 1,357. The Community and Social Services department also plays a significant role, employing 1,194 individuals. This diverse departmental structure reflects a balanced approach to operational efficiency and innovation, ensuring that critical functions are well-supported across the organization.
The geographic distribution of Amgen's workforce is concentrated primarily in California, with Newbury Park housing the largest segment at 2,649 employees, followed by Agoura Hills at 621 and South San Francisco at 600. The presence of 742 locations indicates a broad operational footprint, with a substantial number of employees categorized under 'Other' locations, suggesting a distributed workforce model. This distribution enhances the company's ability to tap into various regional markets and talent pools.
